In this study, we combine in silico and in vivo experiments to ascertain the putative relationship between the binding of the TPP to NRP-1 and the antitumoral effect of the tumor-penetrating and interfering peptides iRGD-IP and Lin TT1-IP in xenograft models of breast cancer. The gene discussed is NRP1; the disease is neoplasm.